Clinical Trials Logo

Opioid Dependence Fentanyl clinical trials

View clinical trials related to Opioid Dependence Fentanyl.

Filter by:
  • Withdrawn  
  • Page 1

NCT ID: NCT04794790 Withdrawn - Clinical trials for Opioid Dependence Fentanyl

Buprenorphine Induction for Fentanyl Dependent Opioid Users

Start date: May 9, 2022
Phase: Early Phase 1
Study type: Interventional

The overall goal of this pilot study is to characterize illicit fentanyl and combination fentanyl and opioid dependence explicitly, by assessing physiologic barriers to effective buprenorphine induction. Results from this pilot study may make a case for a larger feasibility study to be conducted through the Clinical Trials Network at the National Institutes of Drug Abuse. The primary hypothesis is that individuals dependent on illicit fentanyl and combination fentanyl and opioids will have difficulty with standard buprenorphine induction, and will need a modified approach. The primary outcome measure will be retention on buprenorphine at seven days post induction. The secondary outcome measures will be objective precipitated withdrawal and the rate of patients requiring or requesting to initiate methadone due to intolerance of buprenorphine.